Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study of Oliceridine Fumarate Versus Remifentanil for Analgesic Therapy in Mechanically Ventilated Subjects in the ICU

NCT06454292 is registered in ClinicalTrials.gov with Chun Pan as lead sponsor.

NCT NCT06454292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06454292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study of Oliceridine Fumarate Versus Remifentanil for Analgesic Therapy in Mechanically Ventilated Subjects in the ICU
Lead sponsor
Chun Pan
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2024
Completion date
December 31, 2025
Enrollment
292 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia